Tokai Pharmaceuticals Lands $22,000,000 Series D Funding Round

  • Feed Type
  • Date
    5/8/2009
  • Company Name
    Tokai Pharmaceuticals
  • Mailing Address
    One Broadway, 11th floor Cambridge , MA 02142
  • Company Description
    The company develops biopharmaceutical products that focus on endocrine treatment.
  • Website
    http://www.tokaipharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds from the financing will be used to advance Tokai’s lead development candidate, TOK-001, into the clinic for the treatment of advanced prostate cancer.
  • M&A Terms
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Apple Tree Partners

By posting a comment, you agree to our terms and conditions.